Mereo Halts Plans For US Listing

 
• By Lucie Ellis-Taitt
  
Dollar bills
Mereo cites decline of the Nasdaq Biotech Index as one of its reasons for stepping away from a US listing • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business